知镜 Cognispect · 医学文献与研究工作台

Nutritional outcomes associated with enteral versus parenteral nutritional support during intensive induction chemotherapy for acute myeloid leukemia.

Schwarz M, Lebreton A, Lester MA, Marchand T, Houot R, Giltat A, Mokeddem C, Mear JB, Darras E, Orvain C, Hunault M, Tanguy-Schmidt A.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026-08-18 · PMID 42613390

文献摘要

Purpose During acute myeloid leukemia (AML) intensive chemotherapy induction, nutrition is an important part of supportive care and may influence treatment tolerance and clinical outcomes, impacting patient prognosis. Several nutritional supports can be used to limit malnutrition, but limited data are available to guide the choice of nutritional support. This study aimed to compare nutritional outcomes associated with enteral nutrition (EN) and parenteral nutrition (PN) during intensive induction chemotherapy for AML in a real-world retrospective setting. Methods A retrospective observational study was conducted in two French academic centers (Angers University Hospital and Rennes University Hospital), including all adult patients with AML receiving intensive induction chemotherapy. Results Between January 2017 and March 2022, 327 patients were included, with a median age of 60 years (range 18-81). Among these patients, 265 (81%) patients received nutritional support during induction therapy: enteral nutrition (EN) for 135 patients and parenteral nutrition (PN) for 130 patients. Patients who received EN had better nutritional status at the end of induction therapy with lower weight loss (5% vs. 6.7%, P = 0.012), higher albumin levels (32 vs. 27.9, P Conclusion In this retrospective comparison of two institutional nutritional support strategies, patients initially managed with EN experienced lower weight loss and lower rates of severe malnutrition at the end of induction therapy.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。